WHEN: Tuesday, February 4, 2020 – World Cancer Day – 11:30 a.m. to 1:30 p.m.
WHERE: Fairmont Château Laurier, 1 Rideau Street, Ottawa
Durhane Wong-Rieger, President and CEO of CORD, will join a distinguished panel to discuss the risks of the new federal drug price controls on patient access to new medicines and the sustainability of our healthcare system. It is indeed “The Fight FOR Our Lives.”
- Patient perspective: Chris MacLeod, founding partner of Cambridge LLP, Toronto, Founder and Chair of the Canadian Cystic Fibrosis Treatment Society, and a Canadian with cystic fibrosis
- Academic perspective: Dr. Tania Stafinski, PhD, Co-founder and Director, Health Technology and Policy Unit in the School of Public Health at the University of Alberta
- Government and physician perspective: Dr. Yves Bolduc, MD, Physician, former Quebec Health Minister and Special Advisor at Hill+Knowlton Strategies
MODERATOR: Tom Clark, Chair, Global Public Affairs, and former national news anchor
Media are welcome to attend and the event will be streamed on Facebook. Durhane Wong-Rieger and Chris MacLeod are available for interviews at any time on Tuesday, February 4.
About the Canadian Organization for Rare Disorders (CORD)
CORD is Canada’s national network for organizations representing all those with rare disorders. CORD provides a strong common voice to advocate for health policy and a healthcare system that works for those with rare disorders. CORD works with governments, researchers, clinicians and industry to promote research, diagnosis, treatment and services for all rare disorders in Canada. For more information on CORD, visit: www.raredisorders.ca
For further information:
Canadian Organization for Rare Disorders
(647) 801-5176 / email@example.com